Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Shapiro

Showing results (721-730 of 768) with videos related to

Pageof 77
Sort By:
American Journal of Infection Control|December 21, 2025
Targeting the Root: How Behavioral Feedback and Cultural Engagement Transformed Hand Hygiene at a Tertiary Acute Care HospitalAdam G Lipford, Patrick W Johnson, Katie L Kunze, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Developmental Psychology|February 26, 2024
Maternal education prospectively predicts child neurocognitive function: An environmental influences on child health outcomes studySantiago Morales, Maureen E Bowers, Lauren Shuffrey, et al.
Journal of Medicinal Chemistry|February 7, 2015
Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic modelKerry E Murphy-Benenato, Pratik R Bhagunde, April Chen, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
The Journal of Trauma|August 30, 2000
Blunt splenic injury in adults: Multi-institutional Study of the Eastern Association for the Surgery of TraumaA B Peitzman, B Heil, L Rivera, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Critical Care (London, England)|October 26, 2024
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched studyShahin Isha, Prasanth Balasubramanian, Abby J Hanson, et al.
Biomarker Insights|May 19, 2025
Role of Procalcitonin as a Prognostic Biomarker in Hospitalized COVID-19 Patients: A Comparative AnalysisShahin Isha, Lekhya Raavi, Sadhana Jonna, et al.
Pageof 77

Showing results (721-730 of 768) with videos related to

Sort By:
Pageof 77
American Journal of Infection Control|December 21, 2025
Targeting the Root: How Behavioral Feedback and Cultural Engagement Transformed Hand Hygiene at a Tertiary Acute Care HospitalAdam G Lipford, Patrick W Johnson, Katie L Kunze, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Developmental Psychology|February 26, 2024
Maternal education prospectively predicts child neurocognitive function: An environmental influences on child health outcomes studySantiago Morales, Maureen E Bowers, Lauren Shuffrey, et al.
Journal of Medicinal Chemistry|February 7, 2015
Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic modelKerry E Murphy-Benenato, Pratik R Bhagunde, April Chen, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
The Journal of Trauma|August 30, 2000
Blunt splenic injury in adults: Multi-institutional Study of the Eastern Association for the Surgery of TraumaA B Peitzman, B Heil, L Rivera, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Critical Care (London, England)|October 26, 2024
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched studyShahin Isha, Prasanth Balasubramanian, Abby J Hanson, et al.
Biomarker Insights|May 19, 2025
Role of Procalcitonin as a Prognostic Biomarker in Hospitalized COVID-19 Patients: A Comparative AnalysisShahin Isha, Lekhya Raavi, Sadhana Jonna, et al.
Pageof 77